— Know what they know.
Not Investment Advice
Also trades as: BMK.L (LSE) · $vol 0M

BHCCF OTC

Benchmark Holdings plc
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +36579900.0% 1Y: +0.0% 3Y: -53.7% 5Y: -53.7%
$0.37
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Pharmaceuticals · Tech Score Sell · Power 51 · $225.1M mcap · 434M float · 0.0003% daily turnover · Short 100% of daily vol

Cash Flow Trends

Operating Cash Flow
$2M -90.0% ▼
Capital Expenditures
$4M +42.1% ▲
5Y CAGR: -24.3%
Free Cash Flow
-$2M -114.5% ▼
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$13M -10764.3% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
— Operating Activities —
Net Income-$32M-$12M-$30M-$22M-$39M
Depreciation & Amort.$29M$25M$39M$37M$49M
Stock-Based Comp.$2M$830K$1M$1M$2M
Change in Working Capital$5M-$17M-$12M-$1M-$14M
Other Non-Cash Items$10M$12M$17M$4M$4M
Operating Cash Flow-$4M$6M$11M$20M$2M
— Investing Activities —
Capital Expenditures-$11M-$23M-$13M-$6M-$4M
Acquisitions (Net)$17M$112K$1M$644K-$172K
Investment Purchases-$522K-$578K-$378K$0$0
Investment Sales$7M$9K$2M$11K$0
Other Investing$18M$88K-$827K$26K$849K
Investing Cash Flow$30M-$23M-$11M-$5M-$3M
— Financing Activities —
Net Debt Issuance-$2M-$3M-$17M-$6M$6M
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing-$11M-$12M-$10M-$19M-$17M
Financing Cash Flow$30M-$15M-$7M-$12M-$11M
Net Change in Cash$56M-$32M-$3M$126K-$13M
Cash End of Period$72M$39M$36M$37M$23M
Free Cash Flow-$15M-$17M-$2M$13M-$2M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms